PepGen (PEPG) Shares Outstanding (2021 - 2026)
PepGen (PEPG) posted Shares Outstanding (Entity) of $69.2 million for Q1 2026, up 63.82% sequentially from $42.2 million in Q4 2025, and up 111.39% YoY from $32.7 million in Q1 2025.
Analysis
PepGen (PEPG) Shares Outstanding (2021 - 2026) Analysis & Trends
PepGen has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $69.2 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 111.39% year-over-year to $69.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.2 million (up 111.39% YoY) and the FY2025 annual result came in at $42.2 million, up 29.44% from the prior year.
- Shares Outstanding (Entity) rose to $69.2 million in Q1 2026 per PEPG's latest filing, from $42.2 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $69.2 million in Q1 2026 and troughed at $963588.0 in Q1 2022.
- A 5-year average of $28.9 million and a median of $32.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) surged 2535.44% in 2022, then increased 0.77% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $15.6 million in 2022, then surged by 52.33% to $23.8 million in 2023, then jumped by 36.92% to $32.6 million in 2024, then climbed by 29.44% to $42.2 million in 2025, then surged by 63.82% to $69.2 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $69.2 million, $42.2 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | 69.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.20 Mn |
| Mar 31, 2026 | 69.09 Mn |
| Dec 31, 2025 | 42.22 Mn |
| Sep 30, 2025 | 34.36 Mn |
| Jun 30, 2025 | 32.75 Mn |
| Mar 31, 2025 | 32.67 Mn |
| Dec 31, 2024 | 31.58 Mn |
| Sep 30, 2024 | 32.58 Mn |
| Jun 30, 2024 | 32.47 Mn |
| Mar 31, 2024 | 28.66 Mn |
| Dec 31, 2023 | 23.80 Mn |
| Sep 30, 2023 | 23.79 Mn |
| Jun 30, 2023 | 23.79 Mn |
| Mar 31, 2023 | 23.76 Mn |
| Dec 31, 2022 | 15.64 Mn |
| Sep 30, 2022 | 23.56 Mn |
| Jun 30, 2022 | 14.09 Mn |
| Mar 31, 2022 | 963,588.00 |
| Dec 31, 2021 | 901,108.00 |
| Sep 30, 2021 | 894,060.00 |